A UK woman aged 90 was the first in the world to receive the Pfizer vaccine today
The news: The UK started vaccinating its population against covid-19 today, becoming the first country to start distributing the Pfizer-BioNTech vaccine, less than a week after its approval. It is being given to elder-care home workers and people over 80 first, with a 90-year-old woman named Margaret Keenan the first to receive it outside a clinical trial, at University Hospital Coventry. The UK has ordered 40 million doses of the Pfizer-BioNTech vaccine, which is enough to vaccinate 20 million people, or roughly a third of the country’s population. The UK government is expecting to receive a total of 4 million doses of the vaccine by the end of December. The UK has recorded more covid-19 deaths than anywhere else in Europe—over 60,000. Its regulators are currently also considering whether to grant emergency approval for the AstraZeneca-Oxford University covid-19 vaccine candidate, too.
How it’s being administered: The process is complicated by the facts that the vaccine has to be stored in special freezers at -70 °C, it comes in packs of 975 doses that cannot currently be split into smaller batches, and each individual has to receive two doses, three weeks apart. As a result, inoculations are initially being administered from 50 hospital hubs around the country.
What’s happening elsewhere: The US Food and Drug Administration’s vaccine advisory committee is expected to meet on December 10 to decide whether to grant the Pfizer-BioNTech covid-19 vaccine emergency approval, and will meet again on December 17 to consider Moderna’s application for its vaccine. Both Russia and China have already started vaccinating their populations.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Forget designer babies. Here’s how CRISPR is really changing lives
The gene-editing tool is being tested in people, and the first treatment could be approved this year.
Neuroscientists listened in on people’s brains for a week. They found order and chaos.
The study shows that our brains exist between chaos and stability—a finding that could be used to help tweak them either way.
More than 200 people have been treated with experimental CRISPR therapies
But at a global genome-editing summit, exciting trial results were tempered by safety and ethical concerns.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.